Literature DB >> 33382854

Joining forces: Leveraging novel combination therapies to combat infections with eukaryotic pathogens.

Rachel E Ham1,2, Lesly A Temesvari1,2.   

Abstract

Entities:  

Year:  2020        PMID： 33382854      PMCID： PMC7774843          DOI： 10.1371/journal.ppat.1009081

Source DB:  PubMed          Journal:  PLoS Pathog        ISSN： 1553-7366            Impact factor:   6.823


× No keyword cloud information.
  60 in total

1.  Potentiation of antimalarial drug action by chlorpheniramine against multidrug-resistant Plasmodium falciparum in vitro.

Authors:  Sunan Nakornchai; Phattanapong Konthiang
Journal:  Parasitol Int       Date:  2006-06-05       Impact factor: 2.230

2.  Dibenzosuberyl substituted polyamines and analogs of clomipramine as effective inhibitors of trypanothione reductase; molecular docking, and assessment of trypanocidal activities.

Authors:  Mary C O'Sullivan; Timothy B Durham; Hannah E Valdes; Kelly L Dauer; Nicholas J Karney; Andrew C Forrestel; Cyrus J Bacchi; Jerome F Baker
Journal:  Bioorg Med Chem       Date:  2015-01-17       Impact factor: 3.641

3.  Unlocking the Potential of High-Throughput Drug Combination Assays Using Acoustic Dispensing.

Authors:  Grace Ka Yan Chan; Stacy Wilson; Stephen Schmidt; John G Moffat
Journal:  J Lab Autom       Date:  2015-07-09

Review 4.  Nitroimidazole-refractory giardiasis: a growing problem requiring rational solutions.

Authors:  E R Carter; L E Nabarro; L Hedley; P L Chiodini
Journal:  Clin Microbiol Infect       Date:  2017-06-15       Impact factor: 8.067

5.  In vitro and in vivo antitrypanosomal efficacy of combination therapy of Anogeissus leiocarpus, Khaya senegalensis and potash.

Authors:  Abdullah M Tauheed; Mohammed Mamman; Abubakar Ahmed; Mohammed M Suleiman; Emmanuel O Balogun
Journal:  J Ethnopharmacol       Date:  2020-03-31       Impact factor: 4.360

6.  Potentiation of the leishmanicidal activity of nelfinavir in combination with miltefosine or amphotericin B.

Authors:  Elizabeth Valdivieso; Fabiola Mejías; Eugenia Carrillo; Carmen Sánchez; Javier Moreno
Journal:  Int J Antimicrob Agents       Date:  2018-06-30       Impact factor: 5.283

7.  Characterisation of sterol biosynthesis and validation of 14α-demethylase as a drug target in Acanthamoeba.

Authors:  Scott Thomson; Christopher A Rice; Tong Zhang; RuAngelie Edrada-Ebel; Fiona L Henriquez; Craig W Roberts
Journal:  Sci Rep       Date:  2017-08-15       Impact factor: 4.379

8.  Bioactivity of Farnesyltransferase Inhibitors Against Entamoeba histolytica and Schistosoma mansoni.

Authors:  Alexandra Probst; Thi N Nguyen; Nelly El-Sakkary; Danielle Skinner; Brian M Suzuki; Frederick S Buckner; Michael H Gelb; Conor R Caffrey; Anjan Debnath
Journal:  Front Cell Infect Microbiol       Date:  2019-05-29       Impact factor: 5.293

9.  Antileishmanial Activity and Synergistic Effects of Amphotericin B Deoxycholate with Allicin and Andrographolide against Leishmania martiniquensis In Vitro.

Authors:  Nuchpicha Intakhan; Wetpisit Chanmol; Pradya Somboon; Michelle D Bates; Vanessa Yardley; Paul A Bates; Narissara Jariyapan
Journal:  Pathogens       Date:  2020-01-09

10.  Atorvastatin: In-Vivo Synergy with Metronidazole as Anti-Blastocystis Therapy.

Authors:  Maha M A Basyoni; Shawky A Fouad; Marwa F Amer; Ahmed Fathy Amer; Dalia Ibrahim Ismail
Journal:  Korean J Parasitol       Date:  2018-04-30       Impact factor: 1.341
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.